<p>Prostate cancer (PC) is the most common cancer among elderly males in the countries of North America and Europe. The mean age of patients with PC is 72–74 years old. A decision on a treatment option for elderly patients must be based on their somatic status and desire. Today radical operations for locally advanced PC are most commonly performed in older age groups (over 70 years). This is associated with the improvement of both medical equipment and surgical techniques. The patients’ good surgery tolerability is combined with satisfactory oncological results. However, because of age, the regenerative capacities of the patients in this group are diminished and postoperative restorative processes are slower and more difficult. Quality of l...
BACKGROUND: To investigate the outcomes of patients older than 75 years of age in Victoria undergoin...
Background: Many elderly men with high-risk nonmetastatic prostate cancer (HRnMPCa) do not receive r...
OBJECTIVE: To assess the influence of age in pathological findings and clinical evolution of prostat...
Given the demographic trends toward a considerably longer life expectancy, the percentage of elderly...
BackgroundMen aged >65 yr are less likely to receive local therapy for prostate cancer (PCa), per...
Elderly men are likely to be diagnosed with clinically localized prostate cancer, however only few s...
Elderly men are more likely to be diagnosed with aggressive cancer, but are often inappropriately de...
Aim: Radiotherapy can decrease personal satisfaction for prostate disease patients. Our target was t...
Objectives: The aim of this study was to assess whether age >=75 years impairs surgical, functional,...
International audienceRadiotherapy can diminish quality of life (QoL) for prostate cancer patients. ...
Based on the exponential aging of the population and the increasing life expectancy in industrialize...
Contains fulltext : 203364.pdf (publisher's version ) (Closed access)OBJECTIVES: T...
Objective: To assess the influence of age in pathological findings and clinical evolution of prostat...
Radiotherapy can diminish quality of life (QoL) for prostate cancer patients. Our objective was to e...
Objective: To assess the clinicopathological features and overall survival between two groups of Chi...
BACKGROUND: To investigate the outcomes of patients older than 75 years of age in Victoria undergoin...
Background: Many elderly men with high-risk nonmetastatic prostate cancer (HRnMPCa) do not receive r...
OBJECTIVE: To assess the influence of age in pathological findings and clinical evolution of prostat...
Given the demographic trends toward a considerably longer life expectancy, the percentage of elderly...
BackgroundMen aged >65 yr are less likely to receive local therapy for prostate cancer (PCa), per...
Elderly men are likely to be diagnosed with clinically localized prostate cancer, however only few s...
Elderly men are more likely to be diagnosed with aggressive cancer, but are often inappropriately de...
Aim: Radiotherapy can decrease personal satisfaction for prostate disease patients. Our target was t...
Objectives: The aim of this study was to assess whether age >=75 years impairs surgical, functional,...
International audienceRadiotherapy can diminish quality of life (QoL) for prostate cancer patients. ...
Based on the exponential aging of the population and the increasing life expectancy in industrialize...
Contains fulltext : 203364.pdf (publisher's version ) (Closed access)OBJECTIVES: T...
Objective: To assess the influence of age in pathological findings and clinical evolution of prostat...
Radiotherapy can diminish quality of life (QoL) for prostate cancer patients. Our objective was to e...
Objective: To assess the clinicopathological features and overall survival between two groups of Chi...
BACKGROUND: To investigate the outcomes of patients older than 75 years of age in Victoria undergoin...
Background: Many elderly men with high-risk nonmetastatic prostate cancer (HRnMPCa) do not receive r...
OBJECTIVE: To assess the influence of age in pathological findings and clinical evolution of prostat...